EGFR and breast cancer: Moreover, previous studies have shown that regulation of protein localization changes is associated with EGFR/ERK and EGFR/AKT signaling activation in tamoxifen-resistant breast cancer cells, indicating that this may be a potential target for enhancing chemosensitivity of breast cancer patients [70].